PAGE KIDNEY IN WUNDERLICH SYNDROME AFTER DUAL ANTIPLATELET THERAPY
نویسندگان
چکیده
TOPIC: Critical Care TYPE: Medical Student/Resident Case Reports INTRODUCTION: We present a rare case of perinephric hemorrhage causing hypertension & clinically significant bleeding after initiation antiplatelet therapy. CASE PRESENTATION: A 44-year-old male with history medulloblastoma, status post resection irradiation, presented slurred speech ataxia. Cerebral angiogram showed bilateral vertebral artery proximal basilar occlusion, for which he underwent emergent thrombectomy stenting. He was then started on aspirin clopidogrel. day after, complained new-onset severe left flank pain fever, tachycardia, hypertension. Nicardipine drip given to control his blood pressure. Hemoglobin dropped from 15.7 11.4 g/dL. Serum creatinine increased 1.7 baseline 1.2 mg/dL. Urinalysis RBC 10-20/high-power field. Computed tomography (CT) the abdomen large renal subcapsular hematoma measuring 3.0 x 5.7 6.3 cm in size, delayed nephrograms recent endovascular stent placement, indicative function, but no evidence contrast extravasation or rupture. Given patient's stenting, therapy continued. Urology interventional radiology were consulted. The managed conservatively serial hemoglobin checks. Interval CT stable hematoma. Patient later had resolution acute kidney injury, discharged home close follow-up. DISCUSSION: Wunderlich syndrome is phenomenon characterized by sudden onset spontaneous hemorrhage. Due extrinsic compression parenchyma, renin-angiotensin-aldosterone system activated can result systemic known as Page kidney. Up 60% cases are caused neoplasm, smaller portion attributed vasculitis, aneurysm, arteriovenous malformation, vein thrombosis, nephritis, cystic disease, coagulopathy. In our case, there appreciable mass CT. It thought be secondary antiplatelets. Contrast-enhanced has 100% sensitivity gold-standard identifying aid embolization treatment. Management includes selective arterial surgery. Embolization minimally invasive; however, surgical intervention used when tumor needed prevent recurrent bleeding. CONCLUSIONS: life-threatening emergency. high index suspicion warranted patient who pain, hypertension, especially agents. REFERENCE #1: Dopson SJ, et al. cause hypertension: report review literature. Am J Kidney Dis. 2009 Aug;54(2):334-9. doi: 10.1053/j.ajkd.2008.11.014. Epub Jan 23. PMID: 19167799 #2: Lin YY, Diagnosis pain. Hong Kong Med J. 2019 Oct;25(5):406.e1-2. 10.12809/hkmj187718. 31761752 #3: Grassia M, Romano A, Esposito G, five days hemicolectomy colorectal cancer. Int Surg Rep. 2015;16:33-36. doi:10.1016/j.ijscr.2015.09.007 DISCLOSURES: No relevant relationships Luqman Baloch, source=Web Response Janine Beatrice Borja, Shadi Obeidat, Lintu Ramachandran,
منابع مشابه
Duration of dual antiplatelet therapy in acute coronary syndrome
Despite a large volume of evidence supporting the use of dual antiplatelet therapy in patients with acute coronary syndrome, there remains major uncertainty regarding the optimal duration of therapy. Clinical trials have varied markedly in the duration of therapy, both across and within trials. Recent systematic reviews and meta-analyses suggest that shorter durations of dual antiplatelet thera...
متن کاملOptimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome
To prevent recurrent ischaemic events, dual antiplatelet therapy (DAPT) is the standard of care after percutaneous coronary intervention and in the treatment of acute coronary syndrome. Recent evidence supports an adjusted DAPT duration in selected patients.The current paper aims to encourage cardiologists to actively search for patients benefiting from either shorter or prolonged duration DAPT...
متن کاملTriple Versus Dual Antiplatelet Therapy After Coronary Stenting
OBJECTIVES We evaluated safety and efficacy of triple antiplatelet therapy with aspirin, clopidogrel, or ticlopidine and cilostazol after coronary stenting. BACKGROUND Triple antiplatelet therapy might have beneficial effect to prevent thrombotic complications in patients undergoing coronary stenting. METHODS Patients undergoing successful coronary stenting were divided into dual antiplatelet t...
متن کاملSingle versus Dual Antiplatelet Therapy after CABG Surgery
Background: The optimal antiplatelet therapy regimen in the early post-operative CABG period is not well researched. Several studies have proven that use of clopidogrel and aspirin prior to surgery increases bleed risks, but very few studies have examined this therapy post-operatively. Due to the limited amount of data surrounding this topic, the goal of this study was to determine if single or...
متن کاملEfficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.
BACKGROUND Optimal upfront dual antiplatelet therapy (DAPT) duration after complex percutaneous coronary intervention (PCI) with drug-eluting stents (DES) remains unclear. OBJECTIVES This study investigated the efficacy and safety of long-term (≥12 months) versus short-term (3 or 6 months) DAPT with aspirin and clopidogrel according to PCI complexity. METHODS The authors pooled patient-leve...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2021
ISSN: ['0012-3692', '1931-3543']
DOI: https://doi.org/10.1016/j.chest.2021.07.804